Biofrontera (BFRI) Short Interest Ratio & Short Volume → America’s worst nightmare? (From Porter & Company) (Ad) Free BFRI Stock Alerts $1.29 +0.12 (+10.26%) (As of 05/14/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Biofrontera Short Interest DataCurrent Short Volume23,800 sharesPrevious Short Volume44,000 sharesChange Vs. Previous Month-45.91%Dollar Volume Sold Short$43,792.00Short Interest Ratio / Days to Cover0.0Last Record DateApril 30, 2024Outstanding Shares5,090,000 sharesFloat Size3,160,000 sharesShort Percent of Float0.75%Today's Trading Volume76,108 sharesAverage Trading Volume561,531 sharesToday's Volume Vs. Average14% Short Selling Biofrontera ? Sign up to receive the latest short interest report for Biofrontera and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBFRI Short Interest Over TimeBFRI Days to Cover Over TimeBFRI Percentage of Float Shorted Over Time Ad Stocks NewsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarRevolutionizing communication is what this NASDAQ-traded next-gen solution provider is doing. See how this company is well-positioned to capitalize in 2024 Biofrontera Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202423,800 shares $43,792.00 -45.9%0.8%0 $1.84 4/15/202444,000 shares $72,160.00 +26.4%1.2%0.1 $1.64 3/31/202434,800 shares $53,592.00 -58.7%1.0%0 $1.54 3/15/202484,200 shares $130,510.00 -23.7%6.1%0.1 $1.55 2/29/2024110,300 shares $92,398.31 -59.0%10.7%0.2 $0.84 2/15/2024269,100 shares $186,674.67 +806.1%26.1%0.4 $0.69 Get the Latest News and Ratings for BFRI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Biofrontera and its competitors with MarketBeat's FREE daily newsletter. 1/31/202429,700 shares $39,501.00 -4.8%3.0%0.1 $1.33 1/15/202431,200 shares $68,952.00 +3.0%3.2%0.4 $2.21 12/31/202330,300 shares $83,931.00 -13.4%3.1%0.4 $2.77 12/15/202335,000 shares $103,600.00 -31.6%3.5%0.7 $2.96 11/30/202351,200 shares $171,325.44 -5.5%5.4%1.3 $3.35 11/15/202354,200 shares $203,792.00 -60.3%6.1%1.4 $3.76 10/31/2023136,400 shares $641,080.00 +662.0%17.2%3.6 $4.70 10/15/202317,900 shares $120,288.00 +2.9%2.3%0.5 $6.72 9/30/202317,400 shares $152,598.00 -17.1%2.2%1.2 $8.77 9/15/202321,000 shares $178,710.00 +9.4%2.7%1.3 $8.51 8/31/202319,200 shares $166,272.00 -22.9%2.5%0.8 $8.66 8/15/202324,900 shares $230,574.00 -3.5%3.2%1 $9.26 7/31/202325,800 shares $303,150.00 +46.6%0.2%1.1 $11.75 7/15/202317,600 shares $162,976.00 -21.8%0.1%0.7 $9.26 6/30/202322,500 shares $234,000.00 -92.9%0.2%1.5 $10.40 6/15/2023316,400 shares $134,470.00 +46.8%2.1%1.4 $0.43 5/31/2023215,600 shares $101,332.00 -20.4%1.4%2.8 $0.47 5/15/2023270,800 shares $109,674.00 +12.3%1.8%2.8 $0.41 4/30/2023241,200 shares $142,308.00 -8.5%1.6%2.9 $0.59 4/15/2023263,700 shares $156,901.50 -0.1%1.7%2.7 $0.60 3/31/2023263,900 shares $160,979.26 +20.1%1.7%2.5 $0.61 3/15/2023219,800 shares $137,550.84 -7.1%1.4%1.8 $0.63 2/28/2023236,500 shares $175,104.60 -8.8%1.9%1.9 $0.74 2/15/2023259,300 shares $212,496.35 -32.9%2.1%2.3 $0.82 1/31/2023386,200 shares $328,192.76 +3.5%3.1%3.4 $0.85 1/15/2023373,000 shares $372,627.00 -20.2%3.0%4 $1.00 12/30/2022467,400 shares $428,418.84 +17.3%3.7%4.3 $0.92 12/15/2022398,500 shares $354,665.00 -24.9%3.2%3.2 $0.89 11/30/2022530,800 shares $557,340.00 -8.1%4.8%3.7 $1.05 11/15/2022577,500 shares $589,050.00 +6.9%5.2%2.4 $1.02 10/31/2022540,500 shares $583,740.00 +25.3%4.7%1.5 $1.08 10/15/2022431,500 shares $522,115.00 +61.0%3.8%1 $1.21 9/30/2022268,100 shares $281,505.00 +35.3%2.3%0.4 $1.05 9/15/2022198,200 shares $225,948.00 -29.4%1.7%0.3 $1.14Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (Ad)The AI boom continues to snowball with no signs of slowing... Google CEO, Sundar Pichai, made waves during a recent call with analysts, reminding them that the search engine company has been “AI first” since 2016.Get the full story here. BFRI Short Interest - Frequently Asked Questions What is Biofrontera's current short interest? Short interest is the volume of Biofrontera shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 23,800 shares of BFRI short. 0.75% of Biofrontera's shares are currently sold short. Learn More on Biofrontera's current short interest. Which institutional investors are shorting Biofrontera? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Biofrontera: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Biofrontera? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.75% of Biofrontera's floating shares are currently sold short. Is Biofrontera's short interest increasing or decreasing? Biofrontera saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 23,800 shares, a decrease of 45.9% from the previous total of 44,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Biofrontera's float size? Biofrontera currently has issued a total of 5,090,000 shares. Some of Biofrontera's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Biofrontera currently has a public float of 3,160,000 shares. How does Biofrontera's short interest compare to its competitors? 0.75% of Biofrontera's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Biofrontera: NuCana plc (1.21%), Trevena, Inc. (0.08%), Cadrenal Therapeutics, Inc. (0.80%), Virios Therapeutics, Inc. (1.24%), Bionomics Limited (1.45%), Cyclerion Therapeutics, Inc. (0.99%), Vaccinex, Inc. (2.40%), eFFECTOR Therapeutics, Inc. (3.12%), Hepion Pharmaceuticals, Inc. (1.19%), Pasithea Therapeutics Corp. (1.34%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Biofrontera stock? Short selling BFRI is an investing strategy that aims to generate trading profit from Biofrontera as its price is falling. BFRI shares are trading up $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Biofrontera? A short squeeze for Biofrontera occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BFRI, which in turn drives the price of the stock up even further. How often is Biofrontera's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BFRI, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Pulmatrix Short Interest Data ASLAN Pharmaceuticals Short Interest Data Ainos Short Interest Data Vaccinex Short Interest Data Tenax Therapeutics Short Interest Data Processa Pharmaceuticals Short Interest Data Pasithea Therapeutics Short Interest Data Shuttle Pharmaceuticals Short Interest Data Xenetic Biosciences Short Interest Data Cadrenal Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BFRI) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCharles Payne Demystifies OptionsUnstoppable ProsperityThe A.I. story nobody is telling you (Read ASAP)TradeSmith